Navigation Links
Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
Date:12/16/2010

ROCKVILLE, Md., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

"The commencement of the first trial in our small molecule platform represents a major milestone for Neuralstem," said Richard Garr, Neuralstem President & CEO. "In addition to our ongoing programs in cell therapeutics, we are now advancing a new class of orally administered drugs that recruit endogenous neural stem cells.  NSI-189 is the first in this class."

"Today's antidepressants are based on a theory of serotonin deficiency," explained Karl Johe, PhD, Chief Scientific Officer and Chairman of Neuralstem's Board of Directors. "A new theory is emerging that chronic stress can lead to hippocampal atrophy and eventually to depression. NSI-189 appears to help the brain repair itself, generating new neurons and protecting against damage. This neurogenic approach is completely novel in the treatment of CNS diseases."

About NS-189

NS-189 is the first in a class of compounds that Neuralstem plans to develop into orally administered drugs.

In mice, NSI-189 both stimulated neurogenesis of the hippocampus and increased its overall volume as well. Additionally, NSI-189 stimulated neurogenesis of human hippocampus-derived neural stem cells in-vitro. Therefore, NSI-189 may reverse the human hippocampal atrophy seen in major
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
2. Neuralstems ALS Trial on Clinical Hold
3. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
4. Neuralstem Announces Issuance of Core Technology Patent in Europe
5. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
6. Accuray Receives FDA Clearance for the CyberKnife® Systems Lung Optimized Treatment
7. Generex Receives New Patent for Buccal Drug Delivery Platform Technologies
8. Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group
9. Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market
10. Mylan Receives Approval for Generic Version of Adalat® CC Tablets
11. Medical Messengers AstralJet V4 Receives ONC-ATCB 2011/2012 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)...  Boston Scientific has released the primary endpoint ... Failure (NECTAR-HF) clinical trial, the first and only ... (VNS) for the treatment of heart failure patients.  ... Cardiology and Director of the Clinical Investigation Center ... de la Recherche Medicale presented the results at ...
(Date:8/30/2014)... Aug. 30, 2014   Royal Philips  (NYSE: PHG, ... a new ultrasound system designed to enable global ... increasing patient volumes and cost pressures. Making its debut ... in Barcelona this week, Affiniti ... patients with fewer resources deliver high quality patient care. ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research ... Industry, 2009-2019 is a professional and in-depth market ... Scanner industry . The report firstly reviews the ... classification, application and manufacturing technology. The report then ... Crystallography Scanner listing their product specification, capacity, Production ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
(Date:9/1/2014)... honor of National Take Your Cat to the Vet Day, which ... Minnesota (AERC) is offering a few reasons why pet owners should ... don’t take their cat to the vet because “there’s nothing wrong” ... not to take their kid to dentist because he or she ... Just like people want their loved ones to be healthy, they ...
(Date:9/1/2014)... involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) are ... where issues related to claims involving the pain reliever ... Bernstein Liebhard LLP reports. , According to a ... the meeting is scheduled to take place on September ... of several Tylenol conferences that have taken place this ...
(Date:9/1/2014)... 2014 Registration is now open for the ... 1-Mile Race to be held on Sunday, September 21, 2014. ... at Harmon Meadow in Secaucus, New Jersey. All proceeds from ... nonprofit dedicated to restoring a sense of self, restoring the ... our military families. , General registration is $30 with special ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web ... carefully, Top10BestSEOHosting.com is here to announce that JustHost, ... suppliers in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) ... shared hosting plan. The company’s approach to hosting ... affordable, accessible and powerful enough for anyone to ...
(Date:9/1/2014)... Las Vegas, NV (PRWEB) September 01, 2014 ... for entrepreneurs and online marketers that was developed to ... campaign, has caught the attention of Shane Michaels, prompting ... even established entrepreneur, the daily duty of managing all ... online business can be quite overwhelming,” reports Michaels. “That’s ...
Breaking Medicine News(10 mins):Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2
... -- The brains of people with autism concentrate more resources ... in areas used to plan and control thoughts and actions, ... people with autism have exceptional visual abilities, said the researchers ... 26 brain imaging studies that were conducted over 15 years ...
... Breast cancer risk can be assessed by examining ... preliminary study results presented at the AACR 102nd Annual ... method has the potential to provide a personalized assessment ... Arcaro, Ph.D., associate professor of veterinary and animal sciences ...
... Langone Medical Center have investigated a novel protein test ... accurately identify proteins secreted from cancerous tumors caused by ... Association for Cancer Research 102nd Annual Meeting 2011 on ... under the sponsorship of the National Cancer Institute,s Early ...
... , SUNDAY, April 3 (HealthDay News) -- New ... heart attack four years after the city was devastated ... Chronic stress, not being able to return home and ... situation, said the researchers, who updated their two-year post-Hurricane ...
... Health Study revealed that diabetes is associated with lower risk ... other cancers in both men and women. The data, to ... here April 2-6, also showed an association between diabetes and ... an association between diabetes and an increased risk for cancers ...
... SATURDAY, April 2 (HealthDay News) -- In a small preliminary ... number of episodes of a potentially dangerous irregular heartbeat known ... week also improved quality of life, lowering levels of the ... according to research to be presented Saturday at the annual ...
Cached Medicine News:Health News:Brains of People with Autism Focus More on Visual Skills 2Health News:Breast milk may provide a personalized screen of breast cancer risk 2Health News:New test detects early-stage, asbestos-related pulmonary cancer 2Health News:Heart Attack Risk Plagues Post-Katrina New Orleans 2Health News:Avoiding or controlling diabetes may reduce cancer risk and mortality 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 3
... The Laserex Tango ophthalmic laser system provides ... SLT laser and a photodisruptor for posterior ... a frequency-doubled Nd:YAG producing pulsed 532 nm ... producing 1064 nm. The appropriate laser can ...
Extremely thin and smooth jaws, jaws open to 5.5 mm, cross action....
Round handle....
5 mm concave jaws, cross action....
Medicine Products: